Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus combination vs Dacarbazine in advanced melanoma
NCT01614301Phase 2Unknown
- Sponsor
- University of Regensburg
- Start
- May 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in melanoma, sponsored by University of Regensburg. Status: unknown.
02
Drugs
temsirolimus
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01614301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614301.